80 employees
VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.
2020
$38M
from 2 investors over 2 rounds
VectorY raised $38M on June 15, 2021
Investors: Forbion and BGV